摘要
目的为深入研究Tudor-SN蛋白本身在翻译水平的调控机制奠定基础。方法以HeLa细胞全基因组DNA为模板,PCR扩增出目的基因,利用双酶切的方法将目的片段连接到pGL3-Control载体上。再将构建成功的pGL3-5'UTR、pGL3-3'UTR重组质粒分别与内参海肾荧光素酶质粒瞬时共转染HeLa细胞,培养48h检测荧光素酶的活性。结果双酶切和基因测序法鉴定重组质粒构建成功,转染重组质粒后可检测到荧光素酶的活性;以pGL3-5'UTR质粒荧光素酶活性最高。结论成功构建了人Tudor-SN基因5'UTR和3'UTR序列的重组质粒,为研究Tudor-SN基因UTR区对翻译调控的影响奠定了基础。
Objective To lay a foundation for further study on the mechanism of Tudor-SN protein in translation . Methods The human Tudor-SN UTR fragments were amplified by PCR from genomic DNA extracted from HeLa cells , and then were inserted into pGL 3-Control expression vector .HeLa cells were co-transfected with the renilla luciferase plasmid and recombinant pGL3-5′UTR plasmid or pGL3-3′UTR plasmid.After 48 hours, luciferase activity was detected . Results Both double enzyme digestion and gene sequencing confirmed the construction of recombinant plasmid was suc -cessful.The luciferase activity was detected after transfection , and the luciferase activity of pGL3-5′UTR plasmid was the best.Conclusion The recombinant plasmids of pGL 3-5′UTR-luciferase and pGL3-3′UTR-luciferase are successfully con-structed, which lays a foundation for further study of regulatory mechanisms of Tudor -SN genetic UTR in translation .
作者
赵亚丽
苏超
甘世虎
任媛媛
高星杰
杨洁
何津岩
ZHAO Yali SU Chao GAN Shihu REN Yuanyuan GAO Xingjie YANG Jie HE Jinyan(Tianjin Medical University, Tianjin 300070, Chin)
出处
《山东医药》
CAS
北大核心
2017年第4期1-4,共4页
Shandong Medical Journal
基金
国家杰出青年基金资助项目(31125012)
教育部"创新团队发展计划"(IRT13085)
国家自然科学基金资助项目(31170830/31370749/31571380)
天津市应用基础与前沿技术研究计划(青年基金项目)(15JCQNJC09900)
天津医科大学青年基金项目(2015KYZQ03)
关键词
人Tudor-SN蛋白
重组质粒
荧光素酶
5′UTR
3′UTR
human Tudor-SN protein
5′UTR
3′UTR
recombinant plasmid
luciferase